Lota S. Zoth - 03 Jan 2022 Form 4 Insider Report for INOVIO PHARMACEUTICALS, INC. (INO)

Role: Director
Signature: /s/ Lota Zoth
Issuer symbol: INO
Transactions as of: 03 Jan 2022
Net transactions value: -$4,815
Form type: 4
Filing time: 05 Jan 2022, 15:04:05 UTC
Previous filing: 24 May 2021
Next filing: 09 May 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	INO	Common Stock	Options Exercise		+4,090	+19%		25,977	03 Jan 2022	Direct	F1
transaction	INO	Common Stock	Sale	$4,815	-961	-3.7%	$5.01^*	25,016	05 Jan 2022	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	INO	Restricted Stock Unit	Options Exercise	$0	-4,090	-100%	$0.000000^*	0	03 Jan 2022	Common Stock	4,090		Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 12,270 restricted stock units is as follows: 4,090 shares vested on January 3, 2020; 4,090 shares vested on January 3, 2021; 4,090 shares vested on January 3, 2022. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both
F2	The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.